Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak

Por Luis Peñarrubia, Maria Ruiz, Roberto Porco, Sonia N. Rao, Martí Juanola-Falgarona, Davide Manissero, Marta López-Fontanals, Josep Pareja
Publicado em 2020-08-01